Introduction {#S1}
============

The liver is provided of exclusive regenerative capacity after consistent damage of various origin (viral, toxic, metabolic, genetic, or immunologic). Hepatocyte loss is replaced by the remaining functional parenchymal cells in the healthy liver ([@B66]). Nevertheless, a persistent or severe liver damage overwhelms the replication capacity of adult hepatocytes, and injured cells are replaced by the activation/replication of hepatic progenitor cells (HPCs) ([@B24]). HPCs are characterized by an oval-shaped nucleus and a high nucleus-cytoplasm ratio, and express markers of both hepatocyte and biliary lineages ([@B104]). However, the precise characterization of HPCs is a major challenge: even though several markers are now identified and employed, many are not specific for HPCs. Indeed, single markers are not able to accurately identify HPCs, as most of these molecules are either expressed by other hepatic cell types or upregulated upon inflammation ([@B58]). Nevertheless, the simultaneous expression of biliary cytokeratins (e.g., CK7/19) and conventional stem cell markers (e.g., Sox9, CD44, CD133, Epithelial Cell Adhesion Molecule---EpCAM, and Neural Cell Adhesion Molecule---NCAM) may allow HPC unique identification ([@B78]).

HPCs are found in niches located within the smallest branches of the biliary tree, named Canals of Hering, at the interface between the hepatic parenchyma and the portal tract ([@B36]). Further hepatic sites can transiently provide a niche for HPCs, such as the space of Disse and the central vein ([@B14]). Nevertheless, the HPC niche is defined not only by the site where it is located, but also by the composition of the niche. The HPC niche is a special microenvironment composed by different cell types and a scaffold of extracellular matrix, in which cytokines and growth factors released by the niche cells modulate signaling pathways for the regulation of H self-maintenance, proliferation, activation, transition, and differentiation ([@B103]). HPCs in the niche are found in association with other progenitors, such as angioblasts, precursors to hepatic stellate cells and endothelial cells ([@B11]). These progenitors contribute to the stemness of the niche by releasing paracrine signals, which include matrix factors (hyaluronans, types III and IV collagens), minimally sulfated proteoglycans, and laminins and soluble signals such as leukemia inhibitory factor (LIF), hepatocyte growth factor (HGF), stromal derived growth factor (SDGF), and epidermal growth factor (EGF) ([@B11]). In a quiescent state, the niche microenvironment maintains the progenitor phenotype and inhibits cell differentiation. Several types of both acute injury and chronic liver diseases give rise to the "ductular reaction", in which the perturbation of the niche microenvironment starts the differentiation of HPCs toward a hepatocyte or cholangiocyte phenotype ([Figure 1](#F1){ref-type="fig"}). The mechanisms by which HPCs acquire divergent cell fates in the adult liver rely on how the niche microenvironment is modulated to achieve a defined progenitor specification ([@B10]).

![The niche of hepatic progenitor cells (HPCs) in health and disease. HPCs are in the most peripheral and smallest branches of the biliary tree, (canals of Hering). HPCs can be identified by immunohistochemistry through their cytokeratin19-positivity (brown). The top left panel shows a normal portal tract in a healthy human liver. The top right panel is representative of ductular reactions in a sample of a patient affected by non-alcoholic steatohepatitis, in which HPC expansion occurs (Magnification 200x). The bottom panel displays simplified drawings of the niche in both conditions.](fcell-08-00295-g001){#F1}

Since HPC activation is the first step in progenitor-dependent regeneration, a complete knowledge of the mechanisms by which these cells are activated to proliferate and differentiate is important for the development of new therapies for liver disease. The niche is the site of a complex immunological activity mediated by several immune and non-immune cells. Indeed, several cytokines produced by monocytes, macrophages and T-lymphocytes may promote the activation of HPCs in the niche. On the other side, HPCs may be a source of cytokines and chemokines induced by liver inflammation. Several factors released by immune cells which mediate the HPC response to liver damage were described ([@B3]; [@B46], [@B45]; [@B73]). Within the niche, a key signaling to control HPCs activation and proliferation is triggered by macrophages via the tumor-necrosis-factor-like weak inducer of apoptosis (TWEAK) ([@B9]). A further immune-mediated signaling upregulated in human chronic liver diseases consists in the chemokine stromal cell-derived factor 1 (SDF-1) and its receptor (CXCR4): SDF-1 is produced by HPCs and attracts CXCR4-positive inflammatory cells ([@B32]; [@B30]).

Chronic liver diseases are characterized by a disruption of redox balance caused by an excess of reactive species ([@B38]). Reactive species modulate and are modulated by several transcription factors, which may be directly or indirectly involved in the regulation of stem/progenitor cell fate ([@B21]). Even though a direct regulation of HPCs by redox signaling has not been yet demonstrated, the main redox-dependent transcription factors are emerging as determinant and physiological modulators of stem and progenitor cells. The Hypoxia Inducible Factor 1α (HIF-1α) is one of the well-defined redox-dependent modulators of stem cell fate. Since regenerative niches are characterized by a hypoxic environment, cells stabilize HIF-1α which can modulate specific effectors, such as Notch, Wnt and Oct4 that control proliferation, differentiation and pluripotency ([@B64]). Another stress-responsive transcription factor, the Nuclear factor erythroid 2-related factor 2 (NRF2), is a pivotal regulator of both pluripotent and adult stem cell biology in response to various environmental signals ([@B20]). The forkhead box protein (FoxO) family, involved in the resistance to oxidative stress by upregulating antioxidant enzymes, is implicated in the regulation of stem cell maintenance and integrity ([@B70]). Furthermore, cellular actions of reactive species include promotion or suppression of inflammation and immunity ([@B72]; [@B26]). Consequently, the overwhelming production of reactive species could impact the secretory pattern of the immune and non-immune cells within the niche. Nevertheless, this aspect needs to be deepened and broadened by future investigations.

After a basic introduction on redox biology, the present perspective article will focus on redox-dependent pathways involved in immune regulation in liver diseases, providing support for redox signaling as a key factor in the immune-mediated processes of HPCs in the niche.

Redox Biology and Oxidative Stress in Liver Diseases {#S2}
====================================================

Reactive species are highly unstable compounds classified as free radicals (characterized by one or more unpaired electrons in their outer shell) and non-radical derivatives ([Table 1](#T1){ref-type="table"}). These include reactive oxygen (ROS) and e nitrogen species (RNS), also named oxidants ([@B94]). In particular, ROS are mostly (but not exclusively) generated in mitochondria by the electron transport chain ([@B96]; [@B97]), and maintained at low concentrations by both the cytosolic and the mitochondrial antioxidant system, represented by enzymes such as superoxide dismutase, catalase, peroxidases, and non-enzymatic scavengers such as reduced glutathione ([@B62]). Reactive species act as second messengers at low concentrations, being involved in different processes such as apoptosis, cell proliferation, metabolism, and immunity ([@B51]; [@B88]; [@B35]; [@B56]). On the contrary, exceeding oxidants induce oxidative stress, with damage to biological macromolecules, impaired cellular function and compromised cell viability ([@B62]; [@B77]; [@B8]).

###### 

Metabolic reactions give rise to reactive oxygen and nitrogen species (ROS and RNS, respectively), generally named oxidants.

  **Reactive Oxygen Species (ROS)**   **Reactive Nitrogen Species (RNS)**                                  
  ----------------------------------- ------------------------------------- ------------------------------ -----------------------------------
  **O~2~^--^** ∙ Superoxide           **H~2~O~2~** Hydrogen peroxide        **NO** ∙ Nitric Oxide          **ONOO^--^** Peroxynitrite
  **HO** ∙ Hydroxyl                   **^1^O~2~** Singlet oxygen            **NO~2~** ∙ Nitrogen dioxide   **ROONO** Alkyl peroxynitrites
  **HOO** ∙ Hydroperoxyl              **O~3~** Ozone                                                       **N~2~O~3~** Dinitrogen trioxide
  **L** ∙ Lipid radical               **LOOH** Lipid hydroperoxide                                         **N~2~O~4~** Dinitrogen tetroxide
  **LOO** ∙ Lipid peroxyl             **HOCl** Hypochlorite                                                **HNO~2~** Nitrous acid
  **ROO** ∙ Peroxyl                                                                                        **NO~2~^+^** Nitronium anion
  **LO** ∙ Lipid alkoxyl                                                                                   **NO^--^** Nitroxyl anion
  **RS** ∙ Thiyl radical                                                                                   **NO^+^** Nitrosyl cation
  **P** ∙ Protein radical                                                                                  **NO~2~Cl** Nitryl chloride

These reactive species can be classified as free radicals, characterized by one or more unpaired electrons in their outer shell, and non-radical derivatives.

Characterized by intense metabolic activity, the liver is determinant for the overall redox state of the organisms. Several enzymes may produce reactive species in the liver, such as diamine oxidase, dehydrogenases, and the cytochrome P450 system. In particular, mitochondria and cytochrome P450 enzymes in hepatocytes, Kupffer cells, and neutrophils are the main sources of oxidants. Acute and chronic liver diseases are characterized by high production of reactive species ([@B85]), which disrupt metabolism and cell cycle in hepatocytes, activate Kupffer cells, trigger collagen production by stellate cells and angiogenesis ([@B69]).

The progression of liver damage during chronic viral hepatitis is also determined by oxidative stress. Hepatitis B virus (HBV) proteins trigger the production of reactive species: HBV X protein (HBx) localizes within mitochondria and alters transmembrane potential with consequent generation of reactive species ([@B83]; [@B33]; [@B108]), which in turn activate signaling pathways promoting hepatocellular transformation ([@B15]). Oxidative damage in hepatitis C infection is caused by chronic inflammation, iron overload, but also directly by hepatitis C virus (HCV) proteins ([@B17]). Indeed, the non-structural protein 5 A disrupts intracellular Ca^2+^ signaling, triggering mitochondrial production of radical species ([@B28]). Furthermore, the HCV core protein may cause oxidative damage with a direct effect on mitochondria ([@B75]), and HCV proteins disrupt mitochondrial calcium homeostasis, leading to both bioenergetic impairment and nitro-oxidative stress ([@B81]). Increased reactive species production is also extensively described in acute or chronic alcohol consumption and related to the oxidant properties of ethanol ([@B12]). Alcohol is mainly oxidized into acetaldehyde in a NAD^+^-dependent process catalyzed by alcohol dehydrogenase and by the microsomal ethanol oxidation system, based on cytochromes P450. After oxidation, most acetaldehyde is converted into acetate by cytosolic and mitochondrial aldehyde dehydrogenase in another NAD^+^-dependent process. Ethanol oxidation leads to ROS production, mainly hydrogen peroxide and superoxide anion ([@B12]). Since these ROS are characterized by high reactivity and short half-life, they quickly bind to ethanol or iron atoms to form hydroxyl radical, ferrous oxide or hydroxyethyl radical, accounting for lipid peroxidation of cell membranes. Mitochondria (through the respiratory chain), the endoplasmic reticulum (through cytochrome P450) and Kupffer cells (through NADPH oxidase) are the main sources of ROS ([@B57]). An impairment in redox balance is also described in non-alcoholic fatty liver disease (NAFLD), where free fatty acid excess causes overproduction of reactive species mostly by mitochondria and cytochrome P450 ([@B89], [@B91], [@B90]; [@B6], [@B7]), which lead to a pro-oxidative environment triggering the release of pro-inflammatory cytokines, which in turn activate hepatic stellate cells to produce connective tissue; moreover, oxidative stress stimulates Kupffer cells and leads to hepatocellular apoptosis mediated by the expression of death receptor Fas-ligand ([@B48]). Reactive species are the most relevant cause of cellular disruption in hepatic ischemia/reperfusion ([@B5]). Oxidant injury is triggered by Kupffer cells and further amplified by polymorphonuclear leukocytes ([@B39]). Oxidative stress is involved in autoimmune hepatitis, providing a mechanism which links hepatic necroinflammation to fibrogenesis and disease progression ([@B80]). Catalase is one of the autoantigens in primary sclerosing cholangitis, suggesting that a redox unbalance caused by catalase antibodies could contribute to its pathogenesis ([@B76]). Oxidative stress is also a determinant for liver damage during cholestasis ([@B4]), in which it is particularly marked in liver mitochondria ([@B92]). The molecular damage induced by oxidants is also a common pathway to several toxic agents and may lead to drug-induced liver injury, since this organ is the primary entrance for ingested drugs and is provided of several metabolizing enzymes ([@B50]). A classic example of liver redox balance impairment by a toxic compound is provided by acetaminophen, whose hepatic metabolism is mediated by UDP-glucuronosyltransferases, sulfotransferases, and other cytochrome P450 enzymes which produce a reactive intermediate that can bind to sulfhydryl groups, deplete liver glutathione (GSH), and modify cellular proteins, leading to oxidative stress and mitochondrial damage ([@B65]). Chronic inflammation associated with severe oxidative stress mediates hepatocarcinogenesis ([@B87]). The extent of oxidants is increased in hepatocellular carcinoma tissue rather than in non-cancerous liver ([@B37]). Oxidative stress may boost the malignancy of hepatocellular carcinoma by triggering telomerases and angiogenesis ([@B74]; [@B42]).

Redox Modulation of the Hepatic Immune Response {#S3}
===============================================

Oxidative changes are determinant for the immune response and inflammation, which is induced by tissue damage and infection, favoring the removal of damaged/foreign components and resulting in tissue repair. The immune response can be classified into innate and acquired. Innate immunity is a primitive response characterized by lack of specificity, where the main actors are macrophages, neutrophils and dendritic cells, which recognize foreign bodies through the toll-like receptors (TLR) and activate other cells by secreting several cytokines or by presenting antigens on their membrane surfaces ([@B101]). Even though innate immunity is generally considered non-specific and characterized by basic mechanisms, there is consistent evidence to support a high degree of cell type and stimulus specificity in its responses, also showing aspects of immunological memory ([@B95]; [@B99]). On the other side, adaptive immunity is highly specific and systematically organized, providing enduring protection with immunological memory ([@B93]). Cells of the innate immune response may produce high levels of reactive species, leading to tissue damage and inflammation ([@B63]). Other than the oxidative burst, redox balance plays an important role in both the innate and the adaptive immune response, taking part to the macrophage, lymphocyte and dendritic cell signaling, or modulating the cytokine production ([@B109]).

The regulatory effect of oxidants on immunity was first evidenced when hydrogen peroxide at micromolar concentrations was able to activate the transcription factor nuclear factor-κB (NF-κB), a key determinant of the immune response; this effect was largely missing after a co-treatment with the antioxidant N-acetylcysteine ([@B86]). Since then, several investigations addressed the immune-regulatory properties of oxidants in mild concentration, but also of oxidoreductant enzymes ([@B68]).

Impairment of redox balance and the immune response are tightly interconnected in several liver diseases ([Table 2](#T2){ref-type="table"}) ([@B54]). In alcoholic liver disease, chronic ethanol-induced production of reactive species dysregulates the production of cytokines as well as the signaling mediated by the Toll Like Receptor-4 in Kupffer cells ([@B18]). Alcoholic steatohepatitis (ASH) is also determined by the activation of Notch1-NF-κB signaling pathway induced by redox disbalance in hepatocytes ([@B106]). A further study suggested that ethanol exposure triggers a distinct cytokine secretory pattern in Kupffer cells or hepatocytes, since oxidants differentially modulate the production of pro-inflammatory cytokines via NF-κB signaling, mRNA stability, and histone acetylation ([@B22]). Other than ASH, the link between redox alterations and immune response during non-alcoholic steatohepatitis (NASH) is provided by several pieces of evidence. Despite a substantial literature supporting the importance of innate immunity, NASH is characterized by the presence of immunoglobulins against oxidation products, able to recruit B- and T-lymphocytes which in turn amplify the activation of macrophages and natural killer (NK) cells, leading to liver fibrosis ([@B100]). Furthermore, reactive species negatively modulate the immune suppression, promoting the apoptosis of hepatic regulatory T cells and inhibiting the expansion of hepatic myeloid-derived suppressor cells ([@B59]; [@B84]). The immune response triggered by redox imbalance is typically involved in hepatic ischemia-reperfusion injury ([@B82]). Indeed, overproduction of reactive species following reperfusion acutely activates Kupffer cells with consequent release of pro-inflammatory cytokines ([@B40]). Next, elevated oxidant levels amplify the inflammatory cascade through the direct activation of NF-κB, but also increasing the levels of tumor growth factor-β (TGF-β), tumor necrosis factor (TNF), and interleukin-1β ([@B67]). The involvement of redox signaling in immune response is also extensively demonstrated in idiosyncratic drug-induced liver injury, the unpredictable hepatic reaction to drugs ([@B61]). Through redox alterations, several drugs are able to expose hepatocytes to cytokines, such as TNF ([@B29]). For instance, toxicants such as acetaminophen or chlorpromazine disrupt redox balance with consequent activation of c-Jun N-terminal kinase (JNK) and/or inhibition of NF-κB activity, both important in sensitization to TNF ([@B27]).

###### 

A comprehensive but not exhaustive overview on the current knowledge about the main immunologic pathways and redox-dependent mechanisms involved in the pathogenesis of liver diseases.

  **Liver disease**                   **Immune response**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      **Redox involvement**
  ----------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Hepatitis B                         Innate immunity is triggered by viral nucleic acids and proteins. Recruitment of the adaptive immune system, functional development and expansion of distinctive B- and T-cell clones. Generation of a memory response ([@B102]).                                                                                                                                                                                                                                                                                                                                                                                                        Reactive species promote Raf-1 translocation within mitochondria, contributing to the onset of hepatocellular carcinoma ([@B15]).
  Hepatitis C                         HCV replication triggers pathogen-associated molecular patterns (PAMPs), which in turn stimulate IFN and the expression of IFN-stimulated genes (ISGs). IFNs, ISGs, cytokines, and other signals resulting from infected hepatocytes sustain the initiation and modulation of the adaptive immune response ([@B23]).                                                                                                                                                                                                                                                                                                                     Overproduction of reactive species induced by HCV proteins leads to intrahepatocellular events, promoting the progression of hepatic and extrahepatic complications of HCV infection ([@B17]).
  Alcoholic hepatitis                 Early stage: impaired barrier function of the intestinal mucosa leads to increased lipopolysaccharide (LPS) to the portal circulation, with further activation of innate immunity via Toll-like receptors (TLRs). Late stage: alcohol oxidative products inhibit natural killer (NK) cells that induce apoptosis of activated hepatic stellate cells (HSCs) to limit fibrosis. Cytokines produced by inflammatory macrophages and Kupffer cells activate quiescent HSCs, leading to the proliferation of myofibroblasts that produce extracellular matrix proteins. CD8+ T-lymphocytes further contribute to HSCs activation ([@B55]).   Reactive species produced by ethanol metabolism act directly on the transcriptional network that modulates both lipid metabolism and fibrogenesis, also promoting mutagenesis ([@B13]).
  Non-alcoholic fatty liver disease   Innate immunity: activation of the Nod-like receptor protein 3 (NLRP3) inflammasome components and Toll-like receptors (TLRs) by several ligands. Adaptive immunity: activation of Kupffer cells and release of proinflammatory cytokines, leading to the recruitment of bone marrow-derived monocytes and neutrophils that further contribute to the inflammatory response. B cells, Th1- and Th17-derived cytokines worsen the hepatic damage ([@B79]).                                                                                                                                                                                Reactive species promote the release of pro-inflammatory cytokines, which in turn activate hepatic stellate cells to produce connective tissue; moreover, reactive species activate Kupffer cells and lead to hepatocellular apoptosis mediated by the expression of death receptor Fas-ligand ([@B48]).
  Autoimmune hepatitis                The inflammation seems to be secondary to both cell-mediated (T-cell) and humoral (B-cell) activity. A molecular mimicry activates an immune response directed towards self-proteins structurally like foreign pathogens. These proteins activate T cells which initiate and perpetuate liver injury ([@B43]).                                                                                                                                                                                                                                                                                                                           Reactive species production is associated with T-cell activation and proliferation, but continued oxidants exposure induces T-cell hyporesponsiveness ([@B52]).
  Cholestasis                         Cholestatic hepatocytes start inflammatory response by cytokine release, with consequent neutrophil chemotaxis. IL-17 released by neutrophils and Th-cells stimulates Kupffer cells to produce proinflammatory and fibrogenic cytokines ([@B53]).                                                                                                                                                                                                                                                                                                                                                                                        Reactive species are mainly produced by bile acid toxic induction in hepatocytes, and by neutrophils. Oxidants promote proliferation, migration and collagen production by hepatic stellate cells ([@B19]).

Redox Biology and Immune Regulation of Hepatic Progenitor Cells {#S4}
===============================================================

In recent times, more than 170 clinical trials on stem cell-based therapies in liver diseases have been registered. Most of them are testing umbilical cord or bone marrow-derived mesenchymal stem cells, but their transplantation efficiency, clinical reliability, and long-term safety are very concerned ([@B2]). HPCs are considered an alternative source for cell-based therapy, but their survival is low in injured liver ([@B16]). The key to use HPCs for transplantation relies on the effective and stead induction to differentiate into and exert the function of mature hepatocytes. It is then compulsory to define the molecular mechanisms involved in the modulation of HPCs biology, to develop standardized methods for successful human transplantation.

The immune system is becoming evident as a determinant modulator of HPC niches in the adult liver, since several cytokines and chemokines regulate stemness, proliferation, activation, and cell fate of HPCs in physiological and pathological conditions. HPC proliferation occurs with an intrahepatic immune response, characterized by the recruitment of Kupffer cells, dendritic cells, and lymphocytes accounting for local cytokine secretion with mitogen properties ([Figure 2](#F2){ref-type="fig"}), which stimulate HPC expansion ([@B98]). Indeed, early activation of HPCs is triggered by several mediators of the hepatic immune response including TNF, TWEAK, interferon-γ (IFN-γ), interleukin-6, leukemia inhibitory factor, epidermal growth factor (EGF), transforming growth factor-α (TGF-α), and lymphotoxin-β ([@B58]). Most of these cytokines and growth factors are modulated by reactive species and redox signaling. The following observations, mostly coming from gene modified mice and models, are strongly evocative of the involvement of redox alterations in the immune-mediate regulation of HPC quiescence/activation.

![Redox-modulated cellular and molecular immune-mediators of hepatic progenitor cell (HPC) activation in the niche. The immune response triggered by both acute and chronic liver injury is outlined by the involvement of Kupffer cells, dendritic cells, and lymphocytes in the HPC niche. Progenitor activation is then initiated by several cytokines including tumor necrosis factor (TNF), TNF-like weak inducer of apoptosis (TWEAK), interferon-γ, while epidermal growth factor receptor (EGFR) can be activated by transforming growth factor-α (TGF-α). Since these cytokines and corresponding pathways can be redox-modulated, future investigations will clarify the impact of redox alteration in HPC homeostasis through the immune response.](fcell-08-00295-g002){#F2}

TNF-induced HPC activation may be an important component of inflammatory injury in the liver, particularly in chronic inflammation, when TNF and reactive species are secreted simultaneously. Indeed, TNF receptor type 1 knockout mice show impairment of HPC proliferation, and a reduction of TNF-mediated cytosolic oxidant production ([@B47]; [@B31]). In this scenario, redox changes induced by oxidants would expose hepatocytes to the lethal actions of TNF, promoting regeneration via HPCs.

∙ TWEAK induces multiple pathways of cell death via reactive species ([@B71]), indicating that redox signaling could be involved in TWEAK-mediated hepatocellular necrosis, and at the same time suggesting the activation of HPCs. In fact, mice lacking TWEAK receptor (Fn14) do not show any HPC proliferation ([@B41]), and genetic silencing of Fn14 stops the TWEAK-induced production of reactive species in macrophages ([@B60]).

∙ Oxidants exert an inhibitory effect on the production of IFN-γ by T cells ([@B1]), nevertheless hepatic NK cells are resistant to this inhibitory effect ([@B110]). On the other side, IFN-γ receptor knockout mice exhibit a higher rate of reactive species production ([@B25]). Since during T cell-mediated hepatitis, the alteration of IFN-γ secretion impairs hepatocellular regeneration and promotes NK cell-sensitive HPC expansion ([@B34]), this process could be redox-modulated.

∙ The EGF receptor (EGFR) signaling pathways has been demonstrated to regulate the liver progenitor cell compartment ([@B49]). EGFR ligands such as EGF and TGF-α are determinant in the maintenance of HPC phenotype, preventing the epithelial-mesenchymal transition which initiates tumor transformation ([@B107]). Loss of EGFR suppresses HPC differentiation toward cholangiocyte promoting hepatocyte differentiation ([@B44]). Reactive species such as hydrogen peroxide function as second messengers in the modulation of EGFR signaling ([@B105]), suggesting that this pathway could be redox regulated in HPCs during liver diseases.

Taken together, these data represent a solid background on which further specific investigations can be based on.

Conclusion {#S5}
==========

In regenerative niches, low levels of oxidants contribute to the quiescence of stem cells, whereas high amounts of reactive species promote the activation and differentiation of progenitors. Redox alterations play a determinant role in both acute and chronic liver diseases, inhibiting the proliferation of hepatocytes and increasing the number of HPCs. However, the association mechanism between redox imbalance and HPC proliferation is not clearly established. Redox biology is more and more acknowledged as a main contributor to the immune response, nevertheless its role in immune-modulated HPC homeostasis needs to be extensively investigated.

Understanding the underlying molecular mechanisms involved in the redox regulation of immune function in the hepatic progenitor niche will provide significant new insights into the biology of HPCs and liver regeneration.
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